Cephalalgia

From the Editor-in-Chief
pp. 629-629(1)
Author: Goadsby P.J.

Migraine and haemostasis
pp. 630-636(7)
Authors: Crassard I.; Conard J.; Bousser M-G.

Needle acupuncture in tension-type headache: a randomized, placebo-controlled study
pp. 637-642(6)
Authors: Karst M.; Reinhard M.; Thum P.; Wiese B.; Rollnik J.; Fink M.

Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat
pp. 643-655(13)
Authors: Jones M.; Lever I.; Bingham S.; Read S.; McMahon S.; Parsons A.

The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity
pp. 656-663(8)
Authors: Tom B.; De Vries P.; Heiligers J.; Willems E.; Scalbert E.; Delagrange P.; Saxena P.

One-year prevalence of migraine in Sweden: a population-based study in adults
pp. 664-671(8)
Authors: Dahlöf C.; Linde M.

The efficacy and safety of sc Alniditan vs. sc Sumatriptan in the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial
pp. 672-679(8)
Authors: Diener H.; Tfelt-Hansen P.; de Beukelaar F.; Ferrari M.; Olesen J.; Dahlöf C.; Mathew N.

An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients
pp. 680-684(5)
Authors: Pascual J.; Muñoz R.; Leira R.

Sferics and headache: a prospective study
pp. 685-690(6)
Authors: Walach H.; Betz H-D.; Schweickhardt A.

Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache?
pp. 691-696(6)
Authors: Tribl G.; Schnider P.; Wöber C.; Aull S.; Auterith A.; Zeiler K.; Wessely P.

Primary yawning headache
pp. 697-699(3)
Author: Jacome D.

Sumatriptan overdose in episodic cluster headache: a case report of overuse without event
pp. 700-700(1)
Author: Turhal N.S.

SUNCT syndrome: the first case in childhood
pp. 701-702(2)
Authors: D'Andrea G.; Granella F.

Recurrent subdural haematomas in a patient with spontaneous intracranial hypotension
pp. 703-705(3)
Authors: Garc´a-Morales I.; Porta-Etessam J.; Galán L.; Lagares A.; Molina J.

Parkinson's and migraine
pp. 706-707(2)
Authors: Serrano-Dueñas M.

Reply
pp. 707-707(1)
Author: Barbanti P.

Opioid chronopharmacology
pp. 708-708(1)
Author: Fox A.W.

Reply
pp. 708-708(1)
Authors: Silberstein S.; McCrory D.

Unknown Title
pp. 709-709(1)